| Thin and thick filament regulation of contractility in experimental cerebral vasospasm. | |
| | |
MedLine Citation:
|
PMID: 10690734 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Cerebral vasospasm is a potentially fatal consequence of aneurysmal subarachnoid hemorrhage and influences the prognosis of the patient. The purpose of this study was to evaluate the status of thin (actin) and thick (myosin) filament regulation of smooth muscle contraction in the double-subarachnoid hemorrhage canine model of cerebral vasospasm and to determine the effects of a kinase inhibitor reported to be effective in vasospasm, HA1077, on thin and thick filament regulation. METHODS: Cerebral vasospasm was assessed by vertebral angiography. Myosin regulatory light chain phosphorylation was measured using glycerol-urea gels, whereas protein levels of the thin filament-associated protein calponin were measured by Western blot. RESULTS: The basilar arteries of dogs in which subarachnoid hemorrhage was induced narrowed to 36% +/- 2.0% of their size on the first day (n = 12). The phosphorylation of the regulatory light chain tended to increase, but the change did not reach statistical significance (35% +/- 5.9% [n = 12] versus 25% +/- 4.8% [n = 10] in control arteries). In contrast to this increase, significant degradation of calponin was observed in the samples from vasospastic dogs (85.4% +/- 5.45% [n = 5] versus 15.2% +/- 6.21% [n = 5]; P < 0.01). Prophylactic treatment with intravenous injections of HA1077 at 0.67 mg/kg b.i.d. significantly inhibited vasospasm (diameters, 65% +/- 10.2% of Day 1 diameters [n = 5]; P < 0.05), and calponin degradation (57.8% +/- 13.9% [n = 4]) was substantially reduced. CONCLUSION: These data suggest that degradation of the thin filament-associated protein calponin plays a role in cerebral vasospasm and that the antivasospastic action of HA1077 is, at least in part, due to prevention of calponin degradation. |
| | |
Authors:
|
I Kim; B D Leinweber; M Morgalla; W E Butler; M Seto; Y Sasaki; J W Peterson; K G Morgan |
Related Documents
:
|
6111034 - Lipid peroxidation as a cause of cerebral vasospasm. 7993174 - Cerebral aneurysms and arteriovenous malformations: implications for rehabilitation. 10763504 - The relationship of blunt head trauma, subarachnoid hemorrhage, and rupture of pre-exis... 1179734 - The diagnostic pitfalls of subarachnoid hemorrhage from intracranial aneurysms. 20632884 - Balloon test occlusion with hypotensive challenge for main trunk occlusion of internal ... 22066354 - A low-volume tester for the thrombogenic potential of mechanical heart valve prostheses. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Neurosurgery Volume: 46 ISSN: 0148-396X ISO Abbreviation: Neurosurgery Publication Date: 2000 Feb |
Date Detail:
|
Created Date: 2000-03-23 Completed Date: 2000-03-23 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 7802914 Medline TA: Neurosurgery Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 440-6; discussion 446-7 Citation Subset: IM |
Affiliation:
|
Signal Transduction Group, Boston Biomedical Research Institute Massachusetts 02114-2500, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
/
analogs & derivatives*,
pharmacology Actins / physiology* Animals Basilar Artery / drug effects, physiopathology Calcium-Binding Proteins / physiology Dogs Microfilament Proteins Muscle, Smooth, Vascular / drug effects, physiopathology* Myosin Light Chains / physiology Myosins / physiology* Subarachnoid Hemorrhage / physiopathology Vasoconstriction / drug effects, physiology* Vasodilator Agents / pharmacology* Vasospasm, Intracranial / physiopathology* |
| Grant Support | |
ID/Acronym/Agency:
|
HL31704/HL/NHLBI NIH HHS; HL42293/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Actins; 0/Calcium-Binding Proteins; 0/Microfilament Proteins; 0/Myosin Light Chains; 0/Vasodilator Agents; 0/calponin; 103745-39-7/fasudil; 84477-87-2/1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; EC 3.6.4.1/Myosins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Induction of apoptosis in glioma cells by recombinant human Fas ligand.
Next Document: In vivo animal models of cerebral vasospasm: a review.